Dr. Reneau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-3196Fax+1 614-293-4812- Is this information wrong?
Education & Training
University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 2019
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2013 - 2016
Texas A&M; Health Science Center College of MedicineClass of 2013
Certifications & Licensure
OH State Medical License 2019 - 2026
MI State Medical License 2016 - 2021
MN State Medical License 2014 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma Start of enrollment: 2022 May 06
Roles: Contact, Sponsor-Investigator, Principal Investigator
- Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab Start of enrollment: 2020 Sep 15
Roles: Contact, Principal Investigator
- Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma Start of enrollment: 2018 Mar 16
Roles: Principal Investigator, Sponsor-Investigator
- Join now to see all
Publications & Presentations
PubMed
- GATA-3-dependent Gene Transcription is Impaired upon HDAC Inhibition.Geng, X., Wang, C., Abdelrahman, S., Perera, T., Saed, B., Hu, Y., Wolfe, A., Murga-Zamalloa, C., Reneau, J., Wilcox, R.> ;Clinical Cancer Research. 2024 Mar 1
- Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas.Waller, A., Dotson, E., McLaughlin, E., Braunstein, Z., Hanel, W., Reneau, J., Addison, D., Porcu, P., Brammer, J.> ;Leukemia & Lymphoma. 2024 Mar 1
- Presenting features of indolent primary cutaneous B-cell lymphomas: Distinguishing clinical and histopathologic features.Puccio, J., Huang, Y., Reneau, J., Chung, C., Spaccarelli, N., Dulmage, B.> ;Clinics in Dermatology. 2023 Dec 9
- Join now to see all
Hospital Affiliations
Ohio State University Wexner Medical CenterColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
